Published in J Physiol Paris on February 22, 2001
Itinerancy between attractor states in neural systems. Curr Opin Neurobiol (2016) 0.75
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother (1979) 17.49
Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18
Culture of human malaria parasites Plasmodium falciparum. Nature (1976) 5.34
Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol (1990) 3.11
Neural networks with dynamic synapses. Neural Comput (1998) 3.05
Evidence for differences in erythrocyte surface receptors for the malarial parasites, Plasmodium falciparum and Plasmodium knowlesi. J Exp Med (1977) 2.92
Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest (1987) 2.91
A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A. J Cell Biol (1992) 2.19
Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp Parasitol (1983) 2.03
Localization of the 175-kilodalton erythrocyte binding antigen in micronemes of Plasmodium falciparum merozoites. Mol Biochem Parasitol (1992) 1.80
Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect Immun (2000) 1.77
Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Proc Natl Acad Sci U S A (1986) 1.77
Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. Am J Trop Med Hyg (1984) 1.62
Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun (1983) 1.60
Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum. Mol Biochem Parasitol (1990) 1.55
Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors. J Immunol (1986) 1.54
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. J Infect Dis (2000) 1.48
Inhibition of in vitro growth of Plasmodium falciparum by immune serum from monkeys. J Infect Dis (1981) 1.37
Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther (1998) 1.35
Two alleles of the 175-kilodalton Plasmodium falciparum erythrocyte binding antigen. Mol Biochem Parasitol (1993) 1.35
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg (1993) 1.34
A comparison of naproxen and diclofenac sodium in the treatment of osteoarthritis in elderly patients. Br J Clin Pract (1985) 1.34
Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum. J Exp Med (1993) 1.26
Optimal short-term population coding: when Fisher information fails. Neural Comput (2002) 1.23
A newly described activity of guinea pig IgG1 antibodies: transfer of cutaneous basophil reactions. J Immunol (1978) 1.21
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol (1992) 1.20
Studies on the role of red blood cell glycoproteins as receptors for invasion by Plasmodium falciparum merozoites. Mol Biochem Parasitol (1982) 1.18
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J (2001) 1.18
The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther (1999) 1.17
Dynamics of population rate codes in ensembles of neocortical neurons. J Neurophysiol (2004) 1.16
Selective stage-specific changes in the permeability to small hydrophilic solutes of human erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol (1985) 1.16
Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures. Am J Trop Med Hyg (1981) 1.12
Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J Immunol (1987) 1.11
Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients. Int J Clin Pharmacol Ther Toxicol (1982) 1.10
Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175. Exp Parasitol (1994) 1.09
Uncovering the synchronization dynamics from correlated neuronal activity quantifies assembly formation. Biol Cybern (1994) 1.07
Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface by antibodies when schizonts mature in the presence of growth inhibitory immune serum. J Immunol (1986) 1.05
Antibody-mediated basophil accumulations in cutaneous hypersensitivity reactions of guinea pigs. J Immunol (1976) 1.03
Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem (2001) 1.00
Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine. Mol Med (2001) 1.00
Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts. J Exp Med (1980) 0.99
Cuta neous basophil responses in neonatal guinea pigs: active immunization, hapten specific transfer with small amounts of serum, and preferential elicitation with phytohemagglutinin skin testing. J Immunol (1977) 0.98
Localization of the major Plasmodium falciparum glycoprotein on the surface of mature intraerythrocytic trophozoites and schizonts. Mol Biochem Parasitol (1984) 0.98
The pharmacokinetics of cefixime in the fasted and fed state. Eur J Clin Pharmacol (1988) 0.97
Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state. J Clin Pharmacol (1987) 0.96
Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol (2000) 0.96
Study on the possible interaction between tenoxicam and furosemide. Arzneimittelforschung (1987) 0.93
Decreased growth of Plasmodium falciparum in red cells containing haemoglobin E, a role for oxidative stress, and a sero-epidemiological correlation. Trans R Soc Trop Med Hyg (1986) 0.92
Cultured Plasmodium falciparum used as antigen in a malaria indirect fluorescent antibody test. Am J Trop Med Hyg (1978) 0.91
Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth. Bull World Health Organ (1985) 0.90
Specific basophil hypersensitivity induced by skin testing and transferred using immune serum. Nature (1975) 0.87
Gene set analysis for self-contained tests: complex null and specific alternative hypotheses. Bioinformatics (2012) 0.87
Neural correlates of perceptual filling-in of an artificial scotoma in humans. Proc Natl Acad Sci U S A (2007) 0.87
Identification of Plasmodium knowlesi erythrocyte binding proteins. Mol Biochem Parasitol (1988) 0.87
[Topical therapy of arthroses with glucosamines (Dona 200)]. Munch Med Wochenschr (1969) 0.85
Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study. J Neurochem (2000) 0.85
Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2001) 0.83
Subcellular localization of the Triple Gene Block movement proteins of Beet necrotic yellow vein virus by electron microscopy. Virology (2005) 0.82
Optimal neural rate coding leads to bimodal firing rate distributions. Network (2003) 0.82
Protein disulfide isomerase assisted protein folding in malaria parasites. Int J Parasitol (2006) 0.81
Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19). Am J Trop Med Hyg (1998) 0.81
Improved detection and differentiation of poleroviruses infecting beet or rape by multiplex RT-PCR. J Virol Methods (2000) 0.81
Pharmacokinetics of cefixime in the young and elderly. J Antimicrob Chemother (1988) 0.80
Plasmodium falciparum: chymotryptic-like proteolysis associated with a 101-kDa acidic-basic repeat antigen. Exp Parasitol (1992) 0.80
Identification of nonstationary dynamics in physiological recordings. Biol Cybern (2000) 0.80
Memory priming during light anaesthesia with desflurane and remifentanil anaesthesia. Br J Anaesth (2007) 0.80
Recommendations for treating adult and geriatric patients on multimedication. Int J Clin Pharmacol Ther (2014) 0.80
Theory of ocular dominance pattern formation. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.79
Organization of the visual cortex. Nature (1996) 0.79
Endoscopic adrenalectomy for pheochromocytoma: difference between the transperitoneal and retroperitoneal approaches in terms of the operative course. Surg Endosc (2005) 0.78
Characterization of gp195 processed products purified from Plasmodium falciparum culture supernates. Mol Biochem Parasitol (1987) 0.78
Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States. Am J Trop Med Hyg (1996) 0.78
Polyamine oxidase in human retroplacental serum inhibits the growth of Plasmodium falciparum. Am J Trop Med Hyg (1986) 0.78
Worldwide virtual temperatures for product stability testing. J Pharm Sci (1971) 0.78
Recognition of red cells by malaria parasites: the role of erythrocyte-binding proteins. Transfus Med Rev (1991) 0.77
Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma. Langenbecks Arch Surg (1999) 0.77
How can squint change the spacing of ocular dominance columns? J Physiol Paris (2001) 0.77
Serotypic antigens of Plasmodium falciparum recognized by serotype-restricted inhibitory human sera. Am J Trop Med Hyg (1987) 0.77
Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients. J Hum Hypertens (2010) 0.76
Relation between retinotopical and orientation maps in visual cortex. Neural Comput (1999) 0.76
Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Ann Oncol (2001) 0.76
[The status of regional long-term chemotherapy in liver metastasis]. Chirurg (1999) 0.75
Ultrastructure and viability of cryopreserved Plasmodium falciparum. Bull World Health Organ (1977) 0.75
Irregular synchronous activity in stochastically-coupled networks of integrate-and-fire neurons. Network (1998) 0.75
Absorption kinetics of orally administered leucovorin calcium. NCI Monogr (1987) 0.75
The Medical letter on Drugs and Therapeutics. Can Med Assoc J (1961) 0.75
Letter: Content uniformity. J Pharm Sci (1974) 0.75
The Journal and the Press. Can Med Assoc J (1964) 0.75
Evidence for multistability in the visual perception of pigeons. Vision Res (2000) 0.75
Gas gangrene septicemia. A late complication of portacaval shunt. Int Surg (1969) 0.75
Wounds of the Myocardium. Can Med Assoc J (1960) 0.75
[The choice between transperitoneal and retroperitoneal adrenalectomy. A prospective study]. Chirurg (2004) 0.75
Statistical simulation study of new proposed uniformity requirement for bioequivalency studies. J Pharm Sci (1981) 0.75
[Personality, stress and rheumatism: methodologic considerations]. Z Rheumatol (1989) 0.75
[Glucosamine in the therapy of degenerative rheumatism]. Dtsch Med J (1965) 0.75
Relevance of locoregional chemotherapy in patients with liver metastases from colorectal primaries. Swiss Surg (2000) 0.75
[Conditions for medical disability according to section 125 SGB III]. Gesundheitswesen (1999) 0.75
Noncompartmental determination of the absorption rate constant. J Pharm Sci (1986) 0.75